---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-044550"
form_type: "8-K"
ticker: "IDXG"
cik: "0001054102"
company_name: "INTERPACE BIOSCIENCES, INC."
filed_at: "2023-12-12T23:59:59+00:00"
generated_at: "2026-06-07T13:57:32.978654+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Director Robert Gorman resigns from Interpace board, cites compensation dispute

## Summary
- Robert Gorman resigned as director and Chairman effective December 7, 2023.
- Resignation not due to any disagreement with company's operations, policies, or practices.
- Gorman disagreed with timing of proposed change from Executive Chairman to Chairman and reduction in compensation.

## SEC filing metadata
- accession: 0001493152-23-044550
- form_type: 8-K
- ticker: IDXG
- cik: 0001054102
- company_name: INTERPACE BIOSCIENCES, INC.
- filed_at: 2023-12-12T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1054102/000149315223044550/0001493152-23-044550-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1054102/000149315223044550/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-044550
- JSON: https://secwatch.observer/filing/0001493152-23-044550.json
- Plain text: https://secwatch.observer/filing/0001493152-23-044550.txt

## Key facts
- Executive change
  Robert Gorman resigned as Director and Chairman at INTERPACE BIOSCIENCES, INC..
  - Action: resigned
  - Role: Director and Chairman
  source text: On December 7, 2023, Robert Gorman, a Class II director designated by Ampersand 2018 Limited Partnership to the board of directors (the “ Board ”) of Interpace Biosciences, Inc. (the “ Company ”), provided notice to the Company of his resignation as a director and as Chairman of the Board, including as a member of the Board’s Regulatory Compliance Committee, effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1054102/000149315223044550/0001493152-23-044550-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.